NCT00085709 2015-09-30S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLSWOG Cancer Research NetworkPhase 3 Completed637 enrolled 7 charts